Is Envista Holdings Corp (NVST) overvalued? · P/E 56, rev $2.51B
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
This page asks whether Envista Holdings Corp (NVST) looks expensive on cached numbers — not a short thesis.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
NVST currently screens at market cap $3.72B and trailing P/E 55.8. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NVST 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NVST stock page for the full model, not this heading.
Not investment advice.